January 30, 2023
Pharamceutical Technology
Lilly's Jaypirca received FDA approval to treat MCL
Jaypirca is indicated to treat relapsed or refractory MCL in adults, who had at least two lines of sy... See more »
Press Release: DZS Clinical Services : DZS Software Solutions, Inc. Unveils the New ClinPlus® Clinical Platform
BOUND BROOK, N.J., May 29, 2015 /PRNewswire/ -- DZS Software Solutions, a specialty provider of clinical data and trial management software services and solutions, today announced it has developed the ClinPlus® Clinical Platform, a cohesive product that includes both EDC and...
Read full article »
January 31, 2023
MarketScreener
Cambium Networks Increases Momentum in Defense and Security Programs
(marketscreener.com) Rapidly deployable broadband communications infrastructure supports multiple mis... See more »
January 31, 2023
Global Legal Chronicle
Cipla's 15 Million Investment in Ethris GmbH
ADVANT Beiten advised Cipla (EU) Limited on the deal. Cipla (EU) Limited, a wholly-owned subsidiary o... See more »
February 1, 2023Post Online Media
GSK Q4 profit climbs
GSK reported Wednesday that its fourth quarter profit before taxation surged to 1.63 billion pounds f... See more »
February 1, 2023Pharamceutical Technology
Pfizer reports 30% operational growth in full-year 2022 revenues
The company's revenues rose 13% operationally to $24.3bn in the fourth quarter of 2022. The post Pfiz... See more »
January 31, 2023Benzinga
US Court Rejects Johnson & Johnson's Controversial Ploy To Evade Talc Cancer Lawsuits
A federal appeals court in Philadelphia rejected Johnson & Johnson's (NYSE: JNJ) use of chapter 11 ba... See more »
January 30, 2023Pharmabiz
US FDA approves Keytruda as adjuvant treatment following surgical resection and platinumbased chemotherapy for patients with stage IB (T2a =4 centimeters), II, or IIIA NSCLC
Merck, known as MSD outside of the United States and Canada, announced today that the US Food and Dru... See more »
February 1, 2023Cision
MHRA Approves RINVOQ[] (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn's Disease
PRESS RELEASE - For UK Consumer Health, Medical and Trade media only · This approval for... See more »
January 30, 2023PMLiVE
Bristol Myers Squibb's plaque psoriasis treatment recommended by CHMP
At least 100 million people worldwide are impacted by some form of psoriasis... See more »
January 30, 2023
Pharamceutical Technology
Lilly's Jaypirca received FDA approval to treat MCL
Jaypirca is indicated to treat relapsed or refractory MCL in adults, who had at least two lines of sy... See more »
January 31, 2023
MarketScreener
Cambium Networks Increases Momentum in Defense and Security Programs
(marketscreener.com) Rapidly deployable broadband communications infrastructure supports multiple mis... See more »
January 31, 2023
Global Legal Chronicle
Cipla's 15 Million Investment in Ethris GmbH
ADVANT Beiten advised Cipla (EU) Limited on the deal. Cipla (EU) Limited, a wholly-owned subsidiary o... See more »
February 1, 2023Post Online Media
GSK Q4 profit climbs
GSK reported Wednesday that its fourth quarter profit before taxation surged to 1.63 billion pounds f... See more »
February 1, 2023Pharamceutical Technology
Pfizer reports 30% operational growth in full-year 2022 revenues
The company's revenues rose 13% operationally to $24.3bn in the fourth quarter of 2022. The post Pfiz... See more »
January 31, 2023Benzinga
US Court Rejects Johnson & Johnson's Controversial Ploy To Evade Talc Cancer Lawsuits
A federal appeals court in Philadelphia rejected Johnson & Johnson's (NYSE: JNJ) use of chapter 11 ba... See more »
January 30, 2023Pharmabiz
US FDA approves Keytruda as adjuvant treatment following surgical resection and platinumbased chemotherapy for patients with stage IB (T2a =4 centimeters), II, or IIIA NSCLC
Merck, known as MSD outside of the United States and Canada, announced today that the US Food and Dru... See more »
February 1, 2023Cision
MHRA Approves RINVOQ[] (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn's Disease
PRESS RELEASE - For UK Consumer Health, Medical and Trade media only · This approval for... See more »
January 30, 2023PMLiVE
Bristol Myers Squibb's plaque psoriasis treatment recommended by CHMP
At least 100 million people worldwide are impacted by some form of psoriasis... See more »
DZS Software Solutions provides clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry.
Read more